The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Acadia Pharmaceuticals Inc. | COM | 004225108 | 4,318 | 185,000 | SH | OTR | 185,000 | 0 | 0 | ||
| Akero Therapeutics Inc. | COM | 00973Y108 | 17,586 | 831,495 | SH | OTR | 831,495 | 0 | 0 | ||
| Aligos Therapeutics Inc. | COM | 01626L105 | 18,114 | 1,526,048 | SH | OTR | 1,526,048 | 0 | 0 | ||
| Amicus Therapeutics Inc. | COM | 03152W109 | 26,854 | 2,325,000 | SH | OTR | 2,325,000 | 0 | 0 | ||
| Anaptys Bio Inc. | COM | 032724106 | 45,175 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
| Arcus Biosciences Inc. | COM | 03969F109 | 57,961 | 1,432,200 | SH | OTR | 1,432,200 | 0 | 0 | ||
| Atreca Inc. | CL A COM | 04965G109 | 6,673 | 2,202,333 | SH | OTR | 2,202,333 | 0 | 0 | ||
| Avidity Biosciences Inc. | COM | 05370A108 | 26,654 | 1,121,327 | SH | OTR | 1,121,327 | 0 | 0 | ||
| BCLS Acquisition Corp | COM CL A | G0904B105 | 4,900 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| BeiGene Ltd | SPONSORED ADR | 07725L102 | 135,465 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| Bellus Health Inc. | COM NEW | 07987C204 | 25,760 | 3,200,000 | SH | OTR | 3,200,000 | 0 | 0 | ||
| BioAtla Inc. | COM | 09077B104 | 13,473 | 686,347 | SH | OTR | 686,347 | 0 | 0 | ||
| Biomea Fusion Inc. | COM | 09077A106 | 8,854 | 1,188,405 | SH | OTR | 1,188,405 | 0 | 0 | ||
| Black Diamond Therapeutics Inc. | COM | 09203E105 | 10,739 | 2,014,858 | SH | OTR | 2,014,858 | 0 | 0 | ||
| Blueprint Medicines Corp | COM | 09627Y109 | 54,345 | 507,374 | SH | OTR | 507,374 | 0 | 0 | ||
| Cabaletta Bio Inc. | COM | 12674W109 | 2,047 | 540,000 | SH | OTR | 540,000 | 0 | 0 | ||
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 152309100 | 14,088 | 1,251,137 | SH | OTR | 1,251,137 | 0 | 0 | ||
| Codiak Biosciences Inc. | COM | 192010106 | 9,470 | 850,065 | SH | OTR | 850,065 | 0 | 0 | ||
| Cullinan Oncology Inc. | COM | 230031106 | 16,573 | 1,074,082 | SH | OTR | 1,074,082 | 0 | 0 | ||
| Cytokinetics Inc. | COM NEW | 23282W605 | 95,718 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | ||
| Day One Biopharmaceuticals Inc. | COM | 23954D109 | 20,051 | 1,189,943 | SH | OTR | 1,189,943 | 0 | 0 | ||
| DBV Technologies SA | SPONSORED ADR | 23306J101 | 3,415 | 2,134,598 | SH | OTR | 2,134,598 | 0 | 0 | ||
| Elevation Oncology Inc. | COM | 28623U101 | 5,254 | 872,780 | SH | OTR | 872,780 | 0 | 0 | ||
| EQRX Inc. | COM | 26886C107 | 6,820 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
| Essa Pharma Inc. | COM NEW | 29668H708 | 10,288 | 724,500 | SH | OTR | 724,500 | 0 | 0 | ||
| Fate Therapeutics Inc. | COM | 31189P102 | 29,255 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| Gemini Therapeutics Inc. | COM | 36870G105 | 3,783 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
| Genocea Biosciences Inc. | COM NEW | 372427401 | 1,316 | 1,134,453 | SH | OTR | 1,134,453 | 0 | 0 | ||
| GH Research PLC | ORDINARY SHARES | G3855L106 | 23,643 | 1,013,399 | SH | OTR | 1,013,399 | 0 | 0 | ||
| Gossamer Bio Inc. | COM | 38341P102 | 27,849 | 2,462,358 | SH | OTR | 2,462,358 | 0 | 0 | ||
| Health Sciences Acquisition Corp II | ORD SHS | G4411D109 | 4,032 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
| Helix Acquisition Corp | COM CL A | G4444C102 | 3,956 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
| Ideaya Biosciences Inc. | COM | 45166A102 | 52,074 | 2,202,812 | SH | OTR | 2,202,812 | 0 | 0 | ||
| Iovance Biotherapeutics Inc | COM | 462260100 | 20,999 | 1,100,000 | SH | OTR | 1,100,000 | 0 | 0 | ||
| iTeos Therapeutics Inc. | COM | 46565G104 | 202,304 | 4,345,016 | SH | OTR | 4,345,016 | 0 | 0 | ||
| JIYA Acquisition Corp | COM CL A | 47760M102 | 4,885 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| Kinnate Biopharma Inc. | COM | 49705R105 | 32,739 | 1,847,559 | SH | OTR | 1,847,559 | 0 | 0 | ||
| MEI Pharma Inc. | COM NEW | 55279B202 | 7,778 | 2,913,091 | SH | OTR | 2,913,091 | 0 | 0 | ||
| Merus NV | COM | N5749R100 | 60,420 | 1,900,000 | SH | OTR | 1,900,000 | 0 | 0 | ||
| Milestone Pharmaceuticals Inc. | COM | 59935V107 | 14,665 | 2,238,861 | SH | OTR | 2,238,861 | 0 | 0 | ||
| Mirati Therapeutics Inc. | COM | 60468T105 | 293,380 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | ||
| NGM Biopharmaceuticals Inc. | COM | 62921N105 | 8,855 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| Nurix Therapeutics Inc. | COM | 67080M103 | 35,461 | 1,224,892 | SH | OTR | 1,224,892 | 0 | 0 | ||
| Nuvalent Inc | COM | 670703107 | 23,042 | 1,210,192 | SH | OTR | 1,210,192 | 0 | 0 | ||
| Nuvation Bio Inc. | COM CL A | 67080N101 | 36,899 | 4,341,009 | SH | OTR | 4,341,009 | 0 | 0 | ||
| Nuvation Bio Inc. | *W EXP 07/07/202 | 67080N119 | 504 | 266,666 | SH | OTR | 266,666 | 0 | 0 | ||
| Odonate Therapeutics Inc. | COM | 676079106 | 5,680 | 4,207,086 | SH | OTR | 4,207,086 | 0 | 0 | ||
| Omega Alpha SPAC | CL A | G6749V107 | 1,954 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
| Oric Pharmaceuticals Inc. | COM | 68622P109 | 2,940 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
| Panacea Acquisition Corp II | CL A SHS | G6882C106 | 4,850 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| PMV Pharmaceuticals Inc. | COM | 69353Y103 | 65,563 | 2,838,236 | SH | OTR | 2,838,236 | 0 | 0 | ||
| Point Biopharma Global Inc | COM | 730541109 | 14,000 | 2,500,000 | SH | OTR | 2,500,000 | 0 | 0 | ||
| Protara Therapeutics Inc. | COM STK | 74365U107 | 1,412 | 209,227 | SH | OTR | 209,227 | 0 | 0 | ||
| Prothena Corporation PLC | SHS | G72800108 | 14,820 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
| Rain Therapeutics Inc. | COM | 75082Q105 | 15,134 | 1,175,000 | SH | OTR | 1,175,000 | 0 | 0 | ||
| Relay Therapeutics Inc. | COM | 75943R102 | 81,969 | 2,669,132 | SH | OTR | 2,669,132 | 0 | 0 | ||
| Research Alliance Corp II | COM CL A | 760873109 | 4,885 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| Revolution Medicines Inc. | COM | 76155X100 | 87,699 | 3,484,264 | SH | OTR | 3,484,264 | 0 | 0 | ||
| Rocket Pharmaceuticals Inc. | COM | 77313F106 | 32,004 | 1,466,051 | SH | OTR | 1,466,051 | 0 | 0 | ||
| Sage Therapeutics Inc. | COM | 78667J108 | 46,539 | 1,094,000 | SH | OTR | 1,094,000 | 0 | 0 | ||
| Selecta Biosciences Inc. | COM | 816212104 | 10,706 | 3,284,072 | SH | OTR | 3,284,072 | 0 | 0 | ||
| Solid Biosciences Inc. | COM | 83422E105 | 5,561 | 3,177,702 | SH | OTR | 3,177,702 | 0 | 0 | ||
| SPDR SER TR | Call | 78464A900 | 61,578 | 550,000 | SH | Call | OTR | 550,000 | 0 | 0 | |
| SPDR SER TR | S&P BIOTECH | 78464A870 | 246,312 | 2,200,000 | SH | OTR | 2,200,000 | 0 | 0 | ||
| Springworks Therapeutics Inc. | COM | 85205L107 | 128,665 | 2,075,905 | SH | OTR | 2,075,905 | 0 | 0 | ||
| Surrozen Inc | COM | 86889P109 | 1,288 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
| Tango Therapeutics inc | COM | 87583X109 | 75,176 | 6,871,642 | SH | OTR | 6,871,642 | 0 | 0 | ||
| Theseus Pharmaceuticals Inc. | COM | 88369M101 | 11,311 | 892,057 | SH | OTR | 892,057 | 0 | 0 | ||
| Tyra Biosciences Inc | COM | 90240B106 | 90,728 | 6,448,359 | SH | OTR | 6,448,359 | 0 | 0 | ||
| Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 16,818 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
| Xenon Pharmaceuticals Inc. | COM | 98420N105 | 18,744 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||